Bortezomib‐based therapy for relapsed/refractory multiple myeloma in real‐world medical practice

Evangelos Terpos; Eirini Katodritou; Javier de la Rubia; Vânia Hungria; Cyrille Hulin; Μαρία Ρούσσου; Michel Delforge; Greet Bries; Anne‐Marie Stoppa; Jesper Aagesen; Deniz Sargın; Andrew Belch; Lucia Ahlberg; Joris Diels; Robert A. Olie; Don Robinson; M. Spencer; Anna Potamianou; Helgi van de Velde; Meletios A Dimopoulos

doi:10.1111/ejh.13147

Related publications

Article2018

Bortezomib retreatment for relapsed and refractory multiple myeloma in real‐world clinical practice

Cyrille Hulin, Javier de la Rubia, Meletios A Dimopoulos, Evangelos Terpos, Eirini Katodritou, Vânia Hungria, Hadewijch De Samblanx, Anne‐Marie Stoppa, Jesper Aagesen, Deniz Sargın, Anastasia Sioni, Andrew Belch, Joris Diels, Robert A. Olie, Don Robinson, Anna Potamianou, Helgi van de Velde, Michel Delforge

Article2024

Long-Term Follow-up of Real-World Teclistamab Therapy for Relapsed/Refractory Multiple Myeloma from the IMWG Immunotherapy Working Group Committee

Carlyn Tan, Sireesha Asoori, David Nemirovsky, Andriy Derkach, Larissa Brunaldi, Rakesh Popat, Chris Lau, Efstathios Kastritis, Joaquín Martínez‐López, Radhika Bansal, Andre De Menezes Silva Corraes, Saurabh Chhabra, Ricardo Parrondo, Sikander Ailawadhi, Despina Fotiou, Meletios A Dimopoulos, Kwee Yong, Catriona Mactier, Magdalena Corona, Adolfo Jesús Sáez Marín, Hira Mian, Saad Z. Usmani,

Article2022

An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment

Meletios A Dimopoulos, Joseph Mıkhael, Evangelos Terpos, Xavier Leleu, Philippe Moreau, Joan Bladé, Jin Seok Kim, Keith Stockerl‐Goldstein, Paul G. Richardson

Article2022

P926: DARATUMUMAB, BORTEZOMIB AND DEXAMETHASONE FOR TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND SEVERE RENAL IMPAIRMENT: RESULTS FROM THE PHASE 2 GMMG-DANTE TRIAL

Lisa Leypoldt, Maria Gavriatopoulou, Britta Besemer, H. Salwender, Marc‐Steffen Raab, Axel Nogai, Cyrus Khandanpour, V. Runde, Manola Zago, Peter Martus, H. Goldschmidt, Carsten Bokemeyer, Meletios A Dimopoulos, Katja Weisel

Article2023

Real-World Evaluation of Teclistamab for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM)

Sireesha Asoori, Rakesh Popat, Joaquín Martínez‐López, Efstathios Kastritis, Larissa Brunaldi, Radhika Bansal, Andre De Menezes Silva Corraes, Kwee Yong, Catriona Mactier, Magdalena Corona, Adolfo Jesús Sáez Marín, Despina Fotiou, Meletios A Dimopoulos, Saurabh Chhabra, Sikander Ailawadhi, Ricardo Parrondo, Thomas G. Martin, Brian G.M. Durie, Yi Lin